A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS

M.E. Bozik; H. Mitsumoto; B. Brooks; S.A. Rudnicki; D. Moore; B Zhang; A. Ludolph; M. Cudkowicz; L.H. van den Berg; J. Mather; T. Jr. Petzinger; D. Archibald

A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS

Translated title of the contribution: A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS

M.E. Bozik, H. Mitsumoto, B. Brooks, S.A. Rudnicki, D. Moore, B Zhang, A. Ludolph, M. Cudkowicz, L.H. van den Berg, J. Mather, T. Jr. Petzinger, D. Archibald

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS
Original language	Undefined/Unknown
Pages (from-to)	406-413
Number of pages	8
Journal	Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Volume	15
Issue number	5
Publication status	Published - 2014

Keywords

Econometric and Statistical Methods: General
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/25125035

Cite this

Bozik, M. E., Mitsumoto, H., Brooks, B., Rudnicki, S. A., Moore, D., Zhang, B., Ludolph, A., Cudkowicz, M., van den Berg, L. H., Mather, J., Jr. Petzinger, T., & Archibald, D. (2014). A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 15(5), 406-413. http://www.ncbi.nlm.nih.gov/pubmed/25125035

@article{b75e79ab21374f7886388a9f277c4171,

title = "A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS",

keywords = "Econometric and Statistical Methods: General, Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "M.E. Bozik and H. Mitsumoto and B. Brooks and S.A. Rudnicki and D. Moore and B Zhang and A. Ludolph and M. Cudkowicz and {van den Berg}, L.H. and J. Mather and {Jr. Petzinger}, T. and D. Archibald",

year = "2014",

language = "Undefined/Unknown",

volume = "15",

pages = "406--413",

journal = "Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration",

issn = "2167-8421",

publisher = "Informa Healthcare",

number = "5",

}

Bozik, ME, Mitsumoto, H, Brooks, B, Rudnicki, SA, Moore, D, Zhang, B, Ludolph, A, Cudkowicz, M, van den Berg, LH, Mather, J, Jr. Petzinger, T & Archibald, D 2014, 'A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS', Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, vol. 15, no. 5, pp. 406-413. <http://www.ncbi.nlm.nih.gov/pubmed/25125035>

TY - JOUR

T1 - A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS

AU - Bozik, M.E.

AU - Mitsumoto, H.

AU - Brooks, B.

AU - Rudnicki, S.A.

AU - Moore, D.

AU - Zhang, B

AU - Ludolph, A.

AU - Cudkowicz, M.

AU - van den Berg, L.H.

AU - Mather, J.

AU - Jr. Petzinger, T.

AU - Archibald, D.

PY - 2014

Y1 - 2014

KW - Econometric and Statistical Methods: General

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

M3 - Article

SN - 2167-8421

VL - 15

SP - 406

EP - 413

JO - Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

JF - Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

IS - 5

ER -